Economic Factors Affecting the Seasonal Influenza Vaccination Market in East Europe: Ken Research In 2009, a recommendation of the European Union (EU) health Council was issued in order to increase the vaccination of risk groups and healthcare workers in addition to further technical and scientific expertise. The essentiality of this guidance was to provide the EU Member States with relevant information regarding the decision-making process on routine vaccination… Read More »
China Deproteinized Calf Blood Extract Market, 2010-2019: Ken Research As a drug improving energy metabolism, deproteinized calf blood extract has received wide attention due to its efficacy in nervous system. Currently, it is mainly used to treat brain disease, nervous system disease, vascular disease, ulcer, burn, radiation injury and eye disease. Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is… Read More »
China Latanoprost Market, 2010-2019: Ken Research Glaucoma is an irreversible eye disorder which can lead to blindness. According to the statistics published by WHO in 2005, glaucoma is the second- leading cause of blindness after cataract. The number of glaucoma patients around the world is 70 million and will reach 80 million by 2020. And 50% of blindness cases in the… Read More »
China Loversol Market, 2010-2019: Ken Research As a non- ionic contrast medium, ioversol featuring low toxicity and few effects is mainly used to enhance the contrast of blood vessels in medical imaging. Containing iodine, ioversol works based on x- ray attenuation. Contrast medium is commonly used to enhance the visibility of blood vessels and body cavity. And its application area has… Read More »
Parkinsons Disease-Pipeline Review, H2 2016: Ken Research Global Markets Direct’s, ‘Parkinson’s Disease – Pipeline Review, H2 2016’, provides an overview of the Parkinson’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Parkinson’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
China Blood Product Industry, 2011-2016: Ken Research Blood products made by segregating and purifying all kinds of proteins in the blood plasma consists of albumin, immunoglobulin, thrombinogen and other products. China’s enterprises mainly produce 9 kinds of products in the first three categories. The high concentration rate of the global blood product market is embodied in the three companies of developed countries… Read More »
Pancreatic Cancer – Pipeline Review, H2 2016’, provides an overview of the Pancreatic Cancer pipeline landscape- ken Research Global Markets Direct’s, ‘Pancreatic Cancer – Pipeline Review, H2 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
Opportunityanalyzer: Acute Myeloid Leukemia (Aml)-Opportunity Analysis And Forecasts To 2024: Ken Research Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet needs. GlobalData estimates the 2014 sales for AML at approximately $342 million across the 7MM covered in this report.… Read More »
Parkinson’s Disease – Pipeline Review, H2 2016’, provides an overview of the Parkinson’s Disease pipeline landscape- ken Research Global Markets Direct’s, ‘Parkinson’s Disease – Pipeline Review, H2 2016’, provides an overview of the Parkinson’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Parkinson’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
Latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer-Pipeline Review, H2 2016 – Ken Research Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer-Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape. Liver cancer starts in the liver. The risk factors for liver cancer include hepatitis, cirrhosis, or scarring of liver, being male and having low weight at birth. Symptoms include a… Read More »
